Gregory Verdine, PhD

Erving Professor of Chemistry, Harvard University and Vice Chairman, FOG Pharmaceuticals

Gregory L. Verdine is one of Wave’s founders and has served on the board of directors since July 2013. Since 1989, Dr. Verdine has served as the Erving Professor of Chemistry in the Department of Stem Cell and Regenerative Biology and the Department of Chemistry and Chemical Biology at Harvard University and Harvard Medical School; he is now Erving Professor of Chemistry, Emeritus. Dr. Verdine co-founded the non-profit Gloucester Marine Genomics Institute and Gloucester Biotechnology Academy in 2013 and served as the Founding President until 2016. He is the co-founder of Fog Pharmaceuticals Inc., and currently serves as Vice Chairman of the board of directors for the company. He is also President and Chief Executive Officer and serves on the board of directors of LifeMine Therapeutics Inc. Dr. Verdine is also the founder of Warp Drive Bio (merged with Revolution Medicines, Inc.) and served in various roles, including Chief Scientific Officer and Chief Executive Officer, from the company’s inception in 2012 until April 2016. Dr. Verdine founded Enanta Pharmaceuticals and served as a member of its board of directors from 1990 through its initial public offering in 2013. He has served as a Venture Partner at WuXi Healthcare Ventures, AppleTree Ventures, TPG Biotech and Third Rock Ventures. He has served on the Board of Scientific Counselors of the National Cancer Institute and on the Board of Scientific Consultants of the Memorial Sloan Kettering Cancer Center, and Harvard Medical School.